Pfizer pledged $100 million to new industry fund to help fight growing threat of antimicrobial resistance
On Jul. 9, 2020, Pfizer announced it had pledged $100 million to the new Antimicrobial Resistance (AMR) Action…
-
-
Major League Soccer selected OPKO Health’s BioReference Laboratories to provide COVID-19 testing for players and employees
On Jul. 9, 2020, BioReference Laboratories, an OPKO Health company, announced that it will conduct COVID-19 testing for…
-
Mylan and Fujifilm Kyowa Kirin Biologics announced FDA approval of Hulio (adalimumab-fkjp)
On Jul. 9, 2020, Mylan and Fujifilm Kyowa Kirin Biologics announced the the U.S. Food and Drug Administration…
-
Gilead Sciences reported survey findings on PrEP access and utilization in the US during COVID-19 shelter-in-place orders
On Jul. 8, 2020, Gilead Sciences announced data evaluating the impact of COVID-19 shelter-in-place orders (SIPOs) and PrEP…
-
Mount Sinai Health System, Emergent BioSolutions, and ImmunoTek Bio Centers formed collaboration to develop Emergent’s COVID-19 hyperimmune globulin product
On Jul. 8, 2020, the Mount Sinai Health System, Emergent BioSolutions and ImmunoTek Bio Centers announced a collaboration…
-
From lung scarring to heart damage, COVID-19 may leave lingering marks
On Jul. 8, 2020, scientists at the UC Berkeley-UCSF Joint Medical Program reported that for some individuals with…
-
Biotechnology | Clinical Research | COVID-19 | Infectious Disease | NIH | Non-Profit Research | Therapeutics | Vaccine
NIH launched clinical trials network to test COVID-19 vaccines and other prevention tools
On Jul. 8, 2020, the National Institute of Allergy and Infectious Diseases announced it had established a new…
-
Biology | Neurology | NIH | Therapeutics
Outdoor light linked with teens’ sleep and mental health
On Jul. 8, 2020, research showed that adolescents who live in areas that have high levels of artificial…
-
Oxford COVID-19 study reported face masks work, call for immediate adoption
On Jul. 8, 2020, a study from Oxford’s Leverhulme Centre for Demographic Science reported that cloth face coverings,…
-
Moderna completed enrollment of phase 2 study of its mRNA vaccine against COVID-19 (mRNA-1273)
On Jul. 8, 2020, Moderna announced that it had completed enrollment for both cohorts of the Phase 2…
-
Constant Therapeutics’ TXA127 tested in multiple clinical trials for COVID-19 patients
On Jul. 8, 2020, Constant Therapeutics reported that its peptide drug TXA127 was tested in a series of…
-
HPV test missed twice as many women who develop cervical cancer as cotesting
On Jul. 8, 2020, a Health Trends study from researchers at Quest Diagnostics and the University of Pittsburgh…
-
Texas A&M, MD Anderson Scientists tested inhaled therapeutic to protect against COVID-19
On Jul. 8, 2020, scientists from Texas A&M University, biopharmaceutical company Pulmotect and MD Anderson Cancer Center announced…
-
Biotechnology | Diagnostics | Neurology | NIH
Neurofilament light chain outperformed other blood tests to predict and diagnose traumatic brain injury
On Jul. 8, 2020, a study from the National Institutes of Health (NIH) showed that neurofilament light chain…
-
Fred Hutch joined international COVID-19 vaccine effort
On Jul. 8, 2020, the Fred Hutchinson Cancer Research Center was named the coordinating center for vaccine clinical…
-
USDA announced an initial purchase of vaccine for National Animal Vaccine and Veterinary Countermeasures Bank
On Jul. 8, 2020, the United States Department of Agriculture’s (USDA) Animal and Plant Health Inspection Service (APHIS)…
-
First adjuvanted quadrivalent influenza vaccine received EU approval
On Jul. 8, 2020, the European Commission announced regulatory approval for the first adjuvanted quadrivalent influenza vaccine to…
-
BD partnered with U.S. Government on $70 million manufacturing infrastructure project for mass vaccination campaigns
On Jul. 8, 2020, BD (Becton, Dickinson) announced the formation of a strategic, public-private partnership with the Biomedical…
-
Biotechnology | HIV | NIH
Long-acting injectable form of HIV prevention outperformed daily pill in NIH study
On Jul. 7, 2020, a pre-exposure prophylaxis (PrEP) regimen containing an investigational long-acting form of the HIV drug…
-
Oxford scientists formed spinout to launch rapid Covid-19 virus test
On Jul. 7, 2020, scientists from the University of Oxford’s Department of Engineering Science and Oxford Suzhou Centre…
-
GSK and Medicago announced collaboration to develop a novel adjuvanted COVID-19 candidate vaccine
On Jul. 7, 2020, GlaxoSmithKline and Medicago announced a collaboration to develop and evaluate a COVID-19 candidate vaccine…
-
Philips introduced first-of-a-kind mobile ICUs in India to tackle COVID-19 and other emergencies
On Jul. 7, 2020, Royal Philips announced it had introduced first-of-its-kind mobile Intensive Care Units (ICUs) in India….
-
Cerus reported successful inactivation of SARS-CoV-2 with the INTERCEPT Blood System for Plasma
On Jul. 7, 2020, Cerus announced study results demonstrating that the INTERCEPT Blood System inactivates SARS-CoV-2, the causative…
-
In vitro testing of Innovation Pharmas’ Brilacidin for COVID-19 showed consistent anti-SARS-CoV-2 efficacy
On Jul. 7, 2020, Innovation Pharma reported the latest developments related to research into Brilacidin as a potential…
-
Novavax announced $1.6 billion funding from Operation Warp Speed
On Jul. 7, 2020, Novavax announced that it had been selected to participate in Operation Warp Speed, a…
-
LabCorp launched first digital COVID-19 service that improves the doctor and patient experience
On Jul. 7, 2020, LabCorp launched the LabCorp At Home COVID-19 Test Collection Service, the first seamless digital…
-
Regeneron announced manufacturing and supply agreement for BARDA and U.S. DoD for REGN-COV2 anti-viral antibody cocktail
On Jul. 7, 2020, Regeneron announced that, as part of Operation Warp Speed, the Biomedical Advanced Research and…
-
Corvus Pharmaceuticals initiated clinical trial of novel immunotherapy for patients with COVID-19
On Jul. 7, 2020, Corvus Pharmaceuticals announced that it has initiated a Phase 1 study to investigate a…
-
Tonix Pharma announced plans for Massachusetts R&D facility to accelerate clinical development of vaccines and protein-based therapeutics
On Jul. 7, 2020, Tonix Pharmaceuticals announced its intent to purchase an approximately 40,000 square foot facility in…
-
BD launched portable, rapid point-of-care antigen test to detect SARS-CoV-2 in 15 minutes, expanding access to COVID-19 testing
On Jul. 6, 2020, BD (Becton, Dickinson) announced the U.S. Food and Drug Administration (FDA) had granted Emergency…
